Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models. (Q52582241)

3 May 2018

title

Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models. (English)

1 reference

3 May 2018

0 references

0 references

Christopher W Vaughan

4

1 reference

3 May 2018

author name string

Vanessa A Mitchell

1

1 reference

3 May 2018

Ruth Greenwood

2

1 reference

3 May 2018

Angelo Jayamanne

3

1 reference

3 May 2018

publication date

1 November 2007

1 reference

3 May 2018

Clinical and Experimental Pharmacology and Physiology

published in

1 reference

3 May 2018

volume

34

1 reference

3 May 2018

issue

11

1 reference

3 May 2018

page(s)

1186-1190

1 reference

3 May 2018

Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Control of pain initiation by endogenous cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Cellular accumulation of anandamide: consensus and controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Quantitative assessment of tactile allodynia in the rat paw

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Allodynia and hyperalgesia in adjuvant-induced arthritic rats: time course of progression and efficacy of analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

The anandamide transport inhibitor AM404 activates vanilloid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Evidence against the presence of an anandamide transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

Comparison of three rodent neuropathic pain models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04692.X

10.1111/J.1440-1681.2007.04692.X

21 January 2018

Identifiers

DOI

1 reference

3 May 2018

release_4tpzyc3ydbazhlhjl5wwg2i3qu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4tpzyc3ydbazhlhjl5wwg2i3qu

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

17880375

1 reference

3 May 2018